Accuvest Global Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,465
Closed -$272K 87
2025
Q3
$272K Sell
1,465
-34
-2% -$5.83K 0.17% 53
2025
Q2
$229K Sell
1,499
-4,704
-76% -$723K 0.15% 65
2025
Q1
$1.03M Buy
+6,203
New +$971K 0.88% 28
2024
Q4
Sell
-2,974
Closed -$482K 42
2024
Q3
$482K Buy
+2,974
New +$474K 0.41% 44
2024
Q2
Sell
-3,006
Closed -$476K 68
2024
Q1
$476K Sell
3,006
-637
-17% -$101K 0.21% 78
2023
Q4
$571K Sell
3,643
-992
-21% -$152K 0.61% 31
2023
Q3
$722K Sell
4,635
-1,225
-21% -$202K 0.4% 52
2023
Q2
$970K Sell
5,860
-24
-0.4% -$3.87K 0.5% 45
2023
Q1
$912K Sell
5,884
-4,644
-44% -$750K 0.41% 49
2022
Q4
$1.86M Buy
10,528
+5,227
+99% +$903K 0.62% 36
2022
Q3
$866K Buy
5,301
+418
+9% +$70.7K 0.59% 41
2022
Q2
$867K Sell
4,883
-3,358
-41% -$598K 0.56% 47
2022
Q1
$1.46M Buy
8,241
+1,168
+17% +$199K 0.73% 35
2021
Q4
$1.21M Buy
7,073
+1,465
+26% +$240K 0.53% 45
2021
Q3
$920K Sell
5,608
-608
-10% -$104K 0.43% 51
2021
Q2
$1.02M Buy
+6,216
New +$1.03M 0.51% 47
2021
Q1
Sell
-2,216
Closed -$349K 105
2020
Q4
$349K Hold
2,216
1.06% 23
2020
Q3
$330K Sell
2,216
-3,134
-59% -$464K 1.08% 24
2020
Q2
$752K Sell
5,350
-298
-5% -$43.4K 1.98% 22
2020
Q1
$741K Buy
+5,648
New +$801K 2.34% 16
2019
Q1
Sell
-10,194
Closed -$1.32M 119
2018
Q4
$1.32M Buy
10,194
+2,503
+33% +$349K 0.68% 28
2018
Q3
$1.06M Buy
+7,691
New +$1.02M 0.39% 42

Other funds holding JNJ

Accuvest Global Advisors's JNJ Position: Q4 2025 in Review

Accuvest Global Advisors sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 1,465 shares — an estimated $272K sold.

Accuvest Global Advisors first reported a position in JNJ in Q3 2018 and held it in 22 quarters. The position peaked at $1.86M in Q4 2022. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Accuvest Global Advisors reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Accuvest Global Advisors sold 1,465 Johnson & Johnson shares in Q4 2025, an estimated $272K.
  • Accuvest Global Advisors first reported a position in Johnson & Johnson in Q3 2018 and held it in 22 quarters.
  • Accuvest Global Advisors's Johnson & Johnson position peaked at $1.86M in Q4 2022.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Accuvest Global Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.